查詢結果分析
相關文獻
- 探討GLP-1同類藥與DPP4抑制劑
- 黑鯛第一型類胰島素生長因子之融合蛋白質溶解性的研究
- Genetic Analysis of the Insulin Receptor Gene in Chinese Patients with Extreme Insulin Resistance
- Insulin Resistance in Patients with Klinefelter's Syndrome and Idiopathic Gonadotropin Deficiency
- 談胰島素治療
- Cloning and Characterization of Insulin-Like Growth Factor I cDNA from Black Seabream (Acanthopagrus Schlegeli)
- 類胰島素生長因子接合蛋白在胚胎學之作用機轉
- ACARBOSE使用於口服降糖藥物失效之第2型糖尿病患者--臨床評估
- 自我照顧行為、自我效能和社會支持對初期非胰島素依賴型糖尿病患者血糖控制之影響
- Blood Lipid Distrbution in Patients with Newly-Diagnosed, Non-Insulin-Dependent Diabetes Mellitus
頁籤選單縮合
題 名 | 探討GLP-1同類藥與DPP4抑制劑=Exploring GLP-1 Analog and DPP4 Inhibitor |
---|---|
作 者 | 江文心; 王春玉; | 書刊名 | 藥學雜誌 |
卷 期 | 29:1=114 2013.03[民102.03] |
頁 次 | 頁142-146 |
分類號 | 418.271 |
關鍵詞 | 胰島素; 糖尿病衛教師; GLP-1 analog; DPP4 inhibitor; |
語 文 | 中文(Chinese) |
中文摘要 | ADA/EASD 治療指引指出,當初始治療失敗,胰島素應為下一階段藥物之首選,但體重增加、低血糖及注射劑型等因素,使胰島素與第二型糖尿病病人間存在層層心理與生理上的障礙;GLP-1 (glucagon-like peptide-1) 在生理上扮演的角色如:促進葡萄糖依賴型胰島素分泌、恢復對血糖上升的第一相及第二相胰島素反應、延緩胃排空速率、抑制餐後昇糖素的分泌與降低食慾,刺激β細胞的增殖等,使得 GLP-1 analogs 及 DPP4 inhibitors (dipeptidyl peptidase-4) 的發展倍受矚目。本文除了以藥師的觀點探討上述藥物外,也加入糖尿病衛教師觀點,分享病人對注射劑型的恐懼原因及治療對策,期待藥師們能提供適時衛教,增加病人用藥順從性。 |
英文摘要 | According to the ADA/EASD guideline, after the first-line therapy failure, insulin is the preferred second-line choice for patients with type 2 DM. Due to weight gain, hypoglycemia and the injection form, the physical and mental obstacles exist between insulin and the patients with type 2 DM. The physical role of the GLP-1 makes the development of GLP-1 analogs and DPP4 inhibitors becoming the spotlight. This article is focused on the mentioned medicine based on the pharmacists' standpoint and sharing the reason why the patients having the fear about the type of the injection based on the certified diabetes educators' standpoint. We hope pharmacists can offer timely patient education as to improve patient compliance. |
本系統中英文摘要資訊取自各篇刊載內容。